Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19Gabriella d’Ettorre, Claudio Maria Mastroianni, Luigi Celani et al.|Frontiers in Medicine|2020Cited by 218
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)Ernesto Maddaloni, Marco Ridolfi, Luca D’Onofrio et al.|Cardiovascular Diabetology|2020Cited by 114
Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trialFabio Araimo, Francesco Pugliese, Carmela Imperiale et al.|Journal of Medical Virology|2020Cited by 34
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfectionGabriella d’Ettorre, Claudio Maria Mastroianni, Gregorio Egidio Recchia et al.|Medicine|2020Cited by 22